This may be an unpopular opinion, but I'm not sure how our current valuation warrants a buyback. If anything, that is counter-intuitive to the fact that we have just gotten great phase 2 results. If our stance is still to look for best value by keeping our options of going alone open (or at least being seemingly happy to going alone if necessary) then I would assume that the best way of doing this would be to begin multiple phase 3 trials and release those other indications in the mean time.
We either have something, or we don't. I understand risk appetite and investment horizons will differ amongst shareholders, but I think this is a no-brainer from NEU's perspective. If no one comes along with a decent offer, just keep moving along.
Like many here, I'm still in NEU for NNZ2591. To date it has not disappointed, but rather confirmed what we thought we had. Though I would like the share price further north and a TO offer Yesterday, I also realize that valuations tend to be undervalued in almost all Australian Biotechs. It's almost a discount because we're not an American company. Nonetheless, I think our valuation of around $2b is still reasonable in my book given that the market tends to value biotechs at peanuts until Phase 3 results. E.g. IMU is valued around $500m, OPT $700m, CUV $700m.
If we consider NNZ2591 to be equivalent to IMU and OPT, $500-700m, that means Daybue valuation is around $1.3b-1.5billion. My comparisons are not perfect but I want to make the point that, Yes: current MC is cheap, but so are the MC of a number of other biotechs.
Anyhow, I have bought parcels too at our prices as I was hoping $14-$17 might prove to be the low. If not, I guess, might to buy some more...
- Forums
- Charts
- NEU chart
This may be an unpopular opinion, but I'm not sure how our...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.29 |
Change
-0.180(1.24%) |
Mkt cap ! $1.841B |
Open | High | Low | Value | Volume |
$14.47 | $14.53 | $14.22 | $2.245M | 156.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 368 | $14.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.30 | 594 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 641 | 14.270 |
7 | 538 | 14.260 |
17 | 4187 | 14.250 |
3 | 422 | 14.240 |
4 | 608 | 14.230 |
Price($) | Vol. | No. |
---|---|---|
14.280 | 1507 | 12 |
14.290 | 769 | 7 |
14.300 | 783 | 6 |
14.310 | 678 | 7 |
14.320 | 429 | 4 |
Last trade - 12.52pm 03/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |